Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery

NCT02329158 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2018-11-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether disinvestment in hydroxyl-ethyl starches (HES) for patients undergoing cardiac surgery was safe and effective.

Conditions

  • Cardiac Surgical Procedures

Interventions

DRUG

6% hydroxyethyl starch

Sponsors & Collaborators

  • Western University, Canada

    collaborator OTHER
  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-04-30
Completion
2018-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02329158 on ClinicalTrials.gov